Literature DB >> 177362

Factors influencing the production of interferon from L cells.

J M Weber, J L Greenlees, R B Stewart.   

Abstract

The production of interferon from Newcastle disease virus-infected mouse L929 cells was investigated in relation to superinduction procedures, cell density, cellular cyclic adenosine 3',5'-monophosphate (cAMP) levels, and rate of incorporation of 14C-labeled protein hydrolysate into trichloroacetic acid-precipitable material. Densely populated cultures did not have their interferon production enhanced through "superinduction" using cycloheximide, actinomycin D, or the two antimetabolites in combination. These dense cultures produced more interferon per cell than less dense cultures, even though the interferon production from the latter cells could be enhanced two- to threefold by cycloheximide or combined cycloheximide and actinomycin D. Cells in densely populated cultures relative to those from sparsely populated cultures were smaller in volume, had a correspondingly reduced protein content and a lower concentration of cAMP, and were less able to concentrate 14C-labeled protein hydrolysate, although proportionally they were just as efficient in incorporating labeled precursors into trichloroacetic acid-precipitable polypeptides.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177362      PMCID: PMC420615          DOI: 10.1128/iai.13.2.326-331.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Adenosine 3',5'-cyclic monophosphate and contact inhibition.

Authors:  M L Heidrick; W L Ryan
Journal:  Cancer Res       Date:  1971-09       Impact factor: 12.701

3.  Potentiation of human interferon production by superinduction.

Authors:  M W Myers; R M Friedman
Journal:  J Natl Cancer Inst       Date:  1971-10       Impact factor: 13.506

4.  Purification, characterization, and attempts at isotopic labeling of mouse interferon.

Authors:  K Paucker; B J Berman; R R Golgher; D Stancek
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

Review 5.  Biochemistry of interferon and its inducers.

Authors:  W J Kleinschmidt
Journal:  Annu Rev Biochem       Date:  1972       Impact factor: 23.643

6.  Interferon: enhanced synthesis and action in mouse and human cells under suboptimal growth conditions.

Authors:  W A Carter
Journal:  Johns Hopkins Med J       Date:  1972-03

7.  A simple, sensitive method for the assay of adenyl cyclase.

Authors:  G Krishna; B Weiss; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

8.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

9.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

View more
  1 in total

1.  Increase of interferon antiviral activity by exogenous cyclic adenosine-3':5'-monophosphate (cAMP).

Authors:  H Koblet; R Wyler; U Kohler
Journal:  Experientia       Date:  1979-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.